Association of Systemic Immune-inflammation Index and Severity of Diabetic Ketoacidosis in Type 1 Diabetes Mellitus
CompletedOBSERVATIONAL
Enrollment
241
Participants
Timeline
Start Date
August 1, 2021
Primary Completion Date
December 31, 2022
Study Completion Date
November 11, 2023
Conditions
Diabetic Ketoacidosis
Interventions
OTHER
DKA protocol
IV fluids and IV insulin as per guidelines. reference 1-2
Trial Locations (1)
2675
Jahra Hospital, Kuwait
All Listed Sponsors
lead
Jahra Hospital
OTHER
NCT06251895 - Association of Systemic Immune-inflammation Index and Severity of Diabetic Ketoacidosis in Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter